APA (7th ed.) Citation

V, U., K, T., MY, W., EJ, C., A, H., G, D., . . . DM, L. (2023). Commercial Immunoglobulin Products Contain Neutralizing Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 77(7), 950. https://doi.org/10.1093/cid/ciad368

Chicago Style (17th ed.) Citation

V, Upasani, et al. "Commercial Immunoglobulin Products Contain Neutralizing Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 77, no. 7 (2023): 950. https://doi.org/10.1093/cid/ciad368.

MLA (9th ed.) Citation

V, Upasani, et al. "Commercial Immunoglobulin Products Contain Neutralizing Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 77, no. 7, 2023, p. 950, https://doi.org/10.1093/cid/ciad368.